If all the regulatory steps are cleared, shots should be available next week.
A more traditional kind of COVID-19 vaccine is a step closer to becoming the fourth option for U.S. adults.
Moderna's shots are one-quarter the dose of the company's adult shots. Two doses appeared strong enough to prevent severe illness but only about 40% to 50% effective at preventing milder infections. Moderna has added a booster to its study and expects to eventually offer one. The same FDA panel on Tuesday backed Moderna's half-sized shots for ages 6 to 11 and full-sized doses for teens. If authorized by the FDA, it would be the second option for those age groups. Currently Pfizer vaccine is their only choice.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Dogs Can Sniff Out COVID-19 and Signs of Long COVID, Studies SuggestAlmost any dog can be trained to do this type of detection in a matter of weeks, researchers say
Weiterlesen »
FDA advisers to weigh expanding Covid-19 vaccines to younger childrenSeveral months after older children became eligible to get vaccinated against Covid-19, the United States might be just days away from offering vaccines to those younger than 5.
Weiterlesen »
FDA Advisers Considering Moderna’s Covid-19 Vaccine for Ages 6 to 17An advisory committee is set to vote Tuesday on whether to recommend that the Food and Drug Administration authorize use of the Moderna vaccine for 6- to 17-year-olds.
Weiterlesen »
FDA Advisers Back Moderna's COVID-19 Vaccine for Older KidsA government advisory panel Tuesday endorsed a second brand of COVID-19 vaccine for school-age children and teens. The Food and Drug Administration’s outside experts voted unanimously that Moderna’s vaccine is safe and effective enough to give kids ages 6 to 17. If the FDA agrees, it would become the second option for those children, joining Pfizer’s vaccine. The same FDA…
Weiterlesen »
FDA advisers back Moderna’s COVID-19 vaccine for teens, younger kidsA government advisory panel Tuesday endorsed a second brand of COVID-19 vaccine for school-age children and teens.
Weiterlesen »
FDA advisers back Moderna's COVID-19 vaccine for older kidsA government advisory panel has endorsed a second brand of COVID-19 vaccine for school-age children and teens.
Weiterlesen »